Obesity associated disease risk: the role of inherent differences and location of adipose depots

Abstract

Obesity and associated metabolic co-morbidities are a worldwide public health problem. Negative health outcomes associated with obesity, however, do not arise from excessive adiposity alone. Rather, deleterious outcomes of adipose tissue accumulation are a result of how adipocytes are distributed to individual regions in the body. Due to our increased understanding of the dynamic relationship that exists between specific adipose depots and disease risk, an accurate characterization of total body adiposity as well as location is required to properly evaluate a population's disease risk. Specifically, distinctive tissue depots within the body include the lower body, upper body and abdominal (deep and superficial) subcutaneous regions, as well as visceral (mesenteric and omental) regions. Upper body and visceral adipose tissues are highly associated with metabolic dysfunction and chronic disease development, whereas lower body gluteofemoral subcutaneous adipose tissue imparts protection against diet-induced metabolic derangement. Each adipose depot functions distinctly as an endocrine organ hence it has a different level of impact on health outcomes. Effluent from adipose tissue can modulate the functions of other tissues, whilst receiving differential communication from the rest of the body via central nervous system innervation, metabolites and other signaling molecules. More so, adipose depots contain a diverse reservoir of tissue-resident immune cells that play an integral part in both maintaining tissue homeostasis, as well as propagating metabolically-induced inflammation. Overall, the conceptualization of obesity and associated risks needs updating to reflect the complexities of obesity. We review adipose tissue characteristics that are linked to deleterious or beneficial adipose tissue distributions.

Poor sleep quality is associated with obesity and depression in farmers

“…The anthropometric measurement used in this study for obesity was BMI. Because BMI is unable to show differences in lean versus fat body mass, anthropometric measures of adiposity distribution have since been recognized as more indicative of health risk (Bastien, Poirier, Lemieux, & Despres, ; Hill, Solt, & Foster, ; Sam, ). While BMI is still an important screening measurement of obesity associated with sleep deprivation, anthropometrics more reflective of risk prediction should be assessed in future research aimed at determining the impact of sleep deprivation on obesity and depression (Castro et al, ; Jansen et al, ; Lunsford‐Avery, Engelhard, Navar, & Kollins, ).…”

<i>Linum usitatissimum</i> (Flaxseed) Oil during Postpartum Period Contributes to Lean Mass and Healthy Serum Lipid Profile in Rats

“…Fat mass gain, mainly visceral fat, can be associated with postpartum period and parity [27,33]. The accumulation of visceral fat is recognized as a marker of metabolic disorders such as hypertension, changes in lipid metabolism, insulin resistance and thrombotic prevalence [34]. Changes in body fat components during postpartum can be a risk for CND [33,35].…”

Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin‐4′‐sulfonate on Adipogenic Differentiation of Human Bone Marrow‐Derived Mesenchymal Stem Cells through AMPK‐Mediated PPARγ Signaling

“…Obesity is a worldwide health problem, and many diseases such as cardiovascular disease, liver and kidney diseases, diabetes, and cancer are considered to be linked with the prior cases of excess body fat accumulation [ 1 ]. Obesity development occurs through high rates of proliferation and differentiation of white adipocytes, which result in expanding white adipose tissue.…”